Cargando…

The phosphodiesterase 5 inhibitor tadalafil has renoprotective effects in a rat model of chronic kidney disease

Phosphodiesterase 5 inhibitors are widely used to treat erectile dysfunction and lower urinary tract symptoms with benign prostatic hyperplasia. Recent studies have indicated the renoprotective effects of this class of compounds. Whether renoprotection depends on blood pressure reduction remains con...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tomita, Natsumi, Hotta, Yuji, Naiki‐Ito, Aya, Hirano, Kana, Kataoka, Tomoya, Maeda, Yasuhiro, Takahashi, Satoru, Kimura, Kazunori
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7503090/ https://www.ncbi.nlm.nih.gov/pubmed/32889777 http://dx.doi.org/10.14814/phy2.14556

Ejemplares similares

Changes in zinc and manganese concentrations in cisplatin-induced acute kidney injury
por: Yamamoto, Yuko, et al.
Publicado: (2023)

Gosha-Jinki-Gan Improved Erectile Dysfunction Caused by Anti-Cancer Agent Oxaliplatin by Decreasing Transcriptional Expression of Phosphodiesterase-5 in Rats
por: Kataoka, Tomoya, et al.
Publicado: (2022)

Effect of Late Androgen Replacement Therapy on Erectile Function Through Structural Changes in Castrated Rats
por: Kataoka, Tomoya, et al.
Publicado: (2021)

Effects of High Salt Intake on Detrusor Muscle Contraction in Dahl Salt-Sensitive Rats
por: Kawata, Ryoya, et al.
Publicado: (2021)

A review of experimental techniques for erectile function researches and development of medical technology using animal erectile dysfunction models in sexual and reproductive medicine
por: Kataoka, Tomoya, et al.
Publicado: (2023)

Effect of High Testosterone Levels on Endothelial Function in Aorta and Erectile Function in Rats
por: Kataoka, Tomoya, et al.
Publicado: (2022)

Light-controlled relaxation of the rat penile corpus cavernosum using NOBL-1, a novel nitric oxide releaser
por: Hotta, Yuji, et al.
Publicado: (2016)

Proniosomal Gel-Loaded Phosphodiesterase Inhibitors (Sildenafil, Vardenafil, and Tadalafil): Prospects for Topical Penile Therapy of Tadalafil for Treatment of Erectile Dysfunction
por: Mohamed, Soad A., et al.
Publicado: (2023)

Influence of anticancer agents on sexual function: An in vivo study based on the US FDA Adverse Event Reporting System
por: Kataoka, Tomoya, et al.
Publicado: (2021)

The Phosphodiesterase Inhibitor Tadalafil Promotes Splenic Retention of Plasmodium falciparum Gametocytes in Humanized Mice
por: Barbieri, Daniela, et al.
Publicado: (2022)

Hepatitis B infection reported with cancer chemotherapy: analyzing the US FDA Adverse Event Reporting System
por: Sanagawa, Akimasa, et al.
Publicado: (2018)

Evaluating the Effects of Low Carbohydrate and High Protein Diet on Erectile Function in Rats
por: Kataoka, Tomoya, et al.
Publicado: (2022)

Early renoprotection by anemia correction
por: Kuriyama, Satoru
Publicado: (2018)

On the Viability of Tadalafil-Based (18)F-Radiotracers for In Vivo Phosphodiesterase 5 (PDE5) PET Imaging
por: Bailey, Justin J., et al.
Publicado: (2021)

Enhancement of the RhoA/Rho kinase pathway is associated with stress‐related erectile dysfunction in a restraint water immersion stress model
por: Mori, Taiki, et al.
Publicado: (2021)

Efficacy of a Red-Light Controllable Nitric Oxide Releaser for Neurogenic Erectile Dysfunction: A Study Using a Rat Model of Cavernous Nerve Injury
por: Mori, Taiki, et al.
Publicado: (2023)

Tadalafil has biologic activity in human melanoma. Results of a pilot trial with Tadalafil in patients with metastatic Melanoma (TaMe)
por: Hassel, Jessica C., et al.
Publicado: (2017)

Syndrome of Inappropriate Secretion of Antidiuretic Hormone Caused by Carboplatin After Switching from Cisplatin in a Metastatic Urethral Cancer Patient
por: Sugiyama, Yosuke, et al.
Publicado: (2017)

The effect of phosphodiesterase-5 inhibitor, tadalafil, on in vitro potassium chloride-induced contractions of isolated human ureteral tissue
por: Sakthivel, M. S., et al.
Publicado: (2018)

A phosphodiesterase 5 inhibitor, tadalafil, suppresses stromal predominance and inflammation in a rat model of nonbacterial prostatitis
por: Sugimoto, Mikio, et al.
Publicado: (2019)

Phosphodiesterase Type-5 Inhibitor Tadalafil Modulates Steroid Hormones Signaling in a Prostate Cancer Cell Line
por: Bimonte, Viviana M., et al.
Publicado: (2021)

Phosphodiesterase 5 (PDE-5) inhibitors (sildenafil, tadalafil, and vardenafil) effects on esophageal motility: a systematic review
por: Shafiee, Arman, et al.
Publicado: (2023)

Patient preference and satisfaction in erectile dysfunction therapy: a comparison of the three phosphodiesterase-5 inhibitors sildenafil, vardenafil and tadalafil
por: Raheem, Amr Abdel, et al.
Publicado: (2009)

Early-onset fetal growth restriction treated with the long-acting phosphodiesterase-5 inhibitor tadalafil: a case report
por: Sakamoto, Mito, et al.
Publicado: (2016)

Clinical Usefulness of the “MN Criteria” - the Clostridioides difficile Infection Severity Scoring System - in the Japanese Setting
por: Asaoka, Minami, et al.
Publicado: (2022)

Investigation of tolerability and quality of life for carboplatin-based chemotherapy in an elderly urothelial carcinoma patient undergoing hemodialysis: a case report
por: Kondo, Masahiro, et al.
Publicado: (2018)

A BODIPY-picolinium-cation conjugate as a blue-light-responsive caged group
por: Ieda, Naoya, et al.
Publicado: (2023)

Hexane Insoluble Fraction from Purple Rice Extract Retards Carcinogenesis and Castration-Resistant Cancer Growth of Prostate through Suppression of Androgen Receptor Mediated Cell Proliferation and Metabolism
por: Yeewa, Ranchana, et al.
Publicado: (2020)

Tadalafil, a long acting phosphodiesterase inhibitor, promotes bone marrow stem cell survival and their homing into ischemic myocardium for cardiac repair
por: Elmadbouh, Ibrahim, et al.
Publicado: (2017)

Renoprotective Effects of DPP-4 Inhibitors
por: Kawanami, Daiji, et al.
Publicado: (2021)

Anti-Allergic Drug Suppressed Pancreatic Carcinogenesis via Down-Regulation of Cellular Proliferation
por: Kachi, Kenta, et al.
Publicado: (2021)

Treatment satisfaction among men with concurrent benign prostatic hyperplasia and erectile dysfunction treated with tadalafil or other phosphodiesterase type-5 inhibitor combinations
por: Lee, Lulu K, et al.
Publicado: (2016)

Renoprotective effects of garlic
por: Nasri, Hamid
Publicado: (2013)

Renoprotective effects of metformin
por: Nasri, Running Hamid
Publicado: (2013)

The renoprotective effects of sulodexide
por: Olde Engberink, Rik HG, et al.
Publicado: (2016)

Tadalafil in the treatment of erectile dysfunction
por: Coward, Robert M, et al.
Publicado: (2008)

Myopathy with Concurrent Tadalafil and Simvastatin
por: Gargante, Maria Pia, et al.
Publicado: (2009)

A novel model of non-alcoholic steatohepatitis with fibrosis and carcinogenesis in connexin 32 dominant-negative transgenic rats
por: Naiki-Ito, Aya, et al.
Publicado: (2020)

The Anticipated Renoprotective Effects of Sodium-glucose Cotransporter 2 Inhibitors
por: Ito, Marie, et al.
Publicado: (2018)

Sodium glucose transporter‐2 inhibition has no renoprotective effects on non‐diabetic chronic kidney disease
por: Ma, Qiuyue, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_miapp61jhl4t1ggbv9sdn7vog4